Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study

BACKGROUND: The raw costs of mitomycin C (MMC) and oxaliplatin for hyperthermic intraperitoneal chemotherapy (HIPEC) differ substantially. We sought to compare the morbidity and toxicity profiles associated with the use of oxaliplatin and MMC in patients undergoing cytoreductive surgery (CRS) and HI...

Full description

Saved in:
Bibliographic Details
Published in:Can J Surg
Main Authors: Benzaquen, Ella, Wang, Yifan, Wiseman, Stephanie, Rosenfeld, Velka, Sideris, Lucas, Dubé, Pierre, Pelletier, Jean-Sebastien, Vanounou, Tsafrir
Format: Artigo
Language:Inglês
Published: Joule Inc. 2021
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064255/
https://ncbi.nlm.nih.gov/pubmed/33651573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cjs.001619
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items